Psoriasis Increases Risk for Metabolic Syndrome and Coronary Plaque Burden
A novel study evaluated the effect of cardiometabolic syndrome on early vascular disease in patients with psoriasis.
A novel study evaluated the effect of cardiometabolic syndrome on early vascular disease in patients with psoriasis.
Concomitant treatment of common comorbidities of HS, including anxiety and depression, metabolic syndrome, and smoking, may improve treatment outcomes.
A new study confirms that the timing of meals affects cardiometabolic risk factors and the ability to lose weight.
The prevalence of comorbidities in pediatric patients with alopecia areata was determined, using a large de-identified aggregated patient database.
Offspring of women with chronic hypertension were twice as likely to be hospitalized for an endocrine-related issue by the age of 18.
Thyroid dysfunction in patients with psoriasis may be associated with inflammation caused by psoriasis.
The prevalence of metabolic syndrome is rising at an unequal rate among different patient demographics.
Combination therapy with insulin sensitizers may be superior to monotherapy for improvement of hyperandrogenemia and menstrual recovery in polycystic ovary syndrome.
Higher doses anti-tumor necrosis factor-α (anti-TNF-α) therapy may be neceessary for obese patients with ulcerative colitis (UC), according to the findings of a recently published meta-analysis.
Metabolic syndrome is associated with poorer sleep in girls with polycystic ovary syndrome and obesity.